Book contents
- Case Studies in Neuropalliative Care
- Case Studies in Neuropalliative Care
- Copyright page
- Contents
- Contributors
- Section 1 Palliative Care Principles
- Section 2 Cerebrovascular Diseases
- Section 3 Neurodegenerative and Neuromuscular Diseases
- Section 4 Neuro-oncology
- Chapter 33 “I Don’t Want to Be a Burden on My Family”
- Chapter 34 Palliative Amputation for Refractory Pain
- Chapter 35 Chemotherapy-Induced Peripheral Neuropathy
- Chapter 36 “Two Years May Be Too Far Away”
- Chapter 37 Shifting the Goals of Care
- Chapter 38 Management of Seizures in Patients with Glioma from Diagnosis through the End of Life
- Chapter 39 The Burden of Health Care Surrogacy in the Absence of Instruction
- Chapter 40 “But My Brother Should Be Treated”
- Chapter 41 Taking Flight at the End of Life
- Section 5 Pediatric Neurology
- Section 6 Demyelinating Diseases and Autoimmune Neurology
- Index
- References
Chapter 39 - The Burden of Health Care Surrogacy in the Absence of Instruction
from Section 4 - Neuro-oncology
Published online by Cambridge University Press: 08 June 2018
Edited by
Book contents
- Case Studies in Neuropalliative Care
- Case Studies in Neuropalliative Care
- Copyright page
- Contents
- Contributors
- Section 1 Palliative Care Principles
- Section 2 Cerebrovascular Diseases
- Section 3 Neurodegenerative and Neuromuscular Diseases
- Section 4 Neuro-oncology
- Chapter 33 “I Don’t Want to Be a Burden on My Family”
- Chapter 34 Palliative Amputation for Refractory Pain
- Chapter 35 Chemotherapy-Induced Peripheral Neuropathy
- Chapter 36 “Two Years May Be Too Far Away”
- Chapter 37 Shifting the Goals of Care
- Chapter 38 Management of Seizures in Patients with Glioma from Diagnosis through the End of Life
- Chapter 39 The Burden of Health Care Surrogacy in the Absence of Instruction
- Chapter 40 “But My Brother Should Be Treated”
- Chapter 41 Taking Flight at the End of Life
- Section 5 Pediatric Neurology
- Section 6 Demyelinating Diseases and Autoimmune Neurology
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Case Studies in Neuropalliative Care , pp. 134 - 137Publisher: Cambridge University PressPrint publication year: 2018
References
Suggested Reading
Vig, E, Starks, H, Taylor, J, Hopley, E, Fryer, K. Surviving surrogate decision-making: What helps and hampers the experience of making medical decisions for others. J Gen Intern Med. 2007 Sep;22(9):1274–9.CrossRefGoogle ScholarPubMed
Lin, E, Rosenthal, M, Le, B, Eastman, P. Neuro-oncology and palliative care: A challenging interface. Neuro-oncology. 2012;14:iv3–iv7.Google Scholar
Tanaka, S, Meyer, FB, Buckner, JC, Uhm, JH, Yan, ES, Parney, IF. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg. 2013;118:786–98.Google Scholar
Stupp, R, Mason, W, Van den Bent, M, Weller, M, Fisher, B, Taphoorn, M, Belanger, K, Brandes, A, Marosi, C, Bogdahn, U, Curschmann, J, Janzer, R, Ludwin, S, Gorlia, T, Allgeier, A, Lacombe, D, Cairncross, G, Eisenhauer, E, Mirimanoff, R. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352: 987–96.Google Scholar
Sanson, M, Marie, Y, Paris, S, Idbaih, A, Laffaire, J, Ducray, F, El Hallani, S, Boisselier, B, Mokhtari, K, Hoang-Xuan, K, Delattre, JY. Isocitrate Dehydrogenase 1 Codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol. 2009;27(25): 4150–4.Google Scholar
Zhang, K, Wang, XQ, Zhou, B, Zhang, L. The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: A meta-analysis. Familial Cancer. 2013;12: 449–58.Google Scholar
Hemminger, LE, Pittman, C, David, NK, and Mohile, NA. Palliative and end-of-life care in glioblastoma: Defining and measuring opportunities to improve care. Neurooncol Pract. 2016;npw022.CrossRefGoogle Scholar